CPSC Proposes Child-Resistant Packages for Decongestants

Law360, New York (January 25, 2012, 7:58 PM EST) -- The U.S. Consumer Product Safety Commission on Friday proposed a rule requiring child-resistant packaging for eye drops and nasal sprays containing certain decongestants, saying children who accidentally ingest the drugs risk harm to their central nervous and cardiovascular systems.

The proposal would affect over-the-counter medicines with at least 0.08 milligrams of imidazolines — a class of drugs that includes four decongestants — in a single package. It would require the affected products to use child-resistant packaging.

Eye drops such as Visine and Clear Eyes, as well...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.